By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    Setara opens with $90M built from Jazz Pharma pipeline
    By
    msadmin
    November 1, 2026
    Frontier clears FDA hurdle to test a dual-target cancer drug
    By
    msadmin
    November 1, 2026
    Kivo Health raises $10M to bring COPD rehab into the home
    By
    msadmin
    November 1, 2026
    Chatbots order extra tests mainly where doctors already disagree
    Chatbots order extra tests mainly where doctors already disagree
    By
    msadmin
    November 1, 2026
    Zocdoc lets AI agents book real appointments for patients
    Zocdoc lets AI agents book real appointments for patients
    By
    msadmin
    November 1, 2026
  • Spotlight
    SpotlightShow More
    Robinhood Ventures Fund II brings retail capital to healthcare AI
    By
    msadmin
    August 13, 2026
    Adialante brings accessible MRI-based cancer screening
    By
    msadmin
    August 11, 2026
    CellType models biology so AI can discover drugs
    By
    msadmin
    August 11, 2026
    Healthcare AI startups in Robinhood Ventures Fund II
    By
    msadmin
    August 11, 2026
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
  • Articles
    ArticlesShow More
    Singapore clinics let an AI watch for referrals nobody ever sent
    By
    msadmin
    November 1, 2026
    An AI team of agents grades immunotherapy side effects
    By
    msadmin
    October 30, 2026
    Brain implant decoders fail when patients or hardware change, review warns
    By
    msadmin
    October 25, 2026
    Proteomics model picks breast cancer drugs from biopsies
    By
    msadmin
    September 10, 2026
    CRISP model reads frozen sections to steer cancer surgery
    By
    msadmin
    September 10, 2026
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
  • Shop
  • Newsletter
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Follow US
News & Alerts

Chatbots order extra tests mainly where doctors already disagree

A Clalit and Ben-Gurion study finds six leading AI models diverge on unnecessary testing precisely where clinicians themselves disagree.

MedSpark Staff
By
msadmin
MedSpark Staff
Bymsadmin
Medical, Healthcare, & Biotech/Pharma AI News
Follow:
Published: November 1, 2026
Share
2 Min Read
Chatbots order extra tests mainly where doctors already disagree
SHARE

Ask a language model whether a patient needs a scan and the answer depends heavily on which model you ask. Israeli researchers put six of them to the test and found the divergence concentrates in exactly the cases where clinicians argue.

Clalit Health Services and Ben-Gurion University of the Negev built scenarios from the Choosing Wisely campaign, an international effort to discourage low-value tests. Each scenario appeared twice, once where the test was pointless and once where the same test was essential.

Across thousands of responses from models built by Google, Anthropic and OpenAI, the systems proposed an unnecessary test or treatment in 5.4% of cases where intervention was not warranted. They wrongly advised against needed care in 0.6% of cases where it was.

Those totals look reassuring. The pattern beneath them does not. Agreement between models collapsed on scenarios with contested evidence or thin guidelines, the same ground where two experienced physicians might part ways.

Dean Ariel, a family physician at Clalit who led the work, offered a clinical example. Take two backs. A young man who strained his lifting a couch almost never warrants a scan, whereas a woman previously treated for breast cancer whose back pain arrives at night and worsens deserves urgent investigation.

Ariel described the models as inheriting medicine from the text they trained on, including its less disciplined habits. They generally know when to stop, he said, and stumble where doctors hesitate.

The cost of over-ordering is rarely financial alone. An unnecessary MRI can surface a harmless herniation, which then drives referrals, anxiety and occasionally a procedure nobody needed.

The study suggests a specific role for these tools. They may be safest handling the clear cases and flagging contested ones for human judgment rather than resolving them alone.

TAGGED:Choosing WiselyClinical Decision Supporthealth economicsIsraellarge language modelsoverdiagnosisprimary care
SOURCES:J-Wire
Share This Article
Facebook Copy Link Print
MedSpark Staff
Bymsadmin
Follow:
Medical, Healthcare, & Biotech/Pharma AI News

You Might Also Like

News & Alerts

Altman-backed Merge Labs licenses Butterfly chips to link brains

By
msadmin
September 5, 2026
News & Alerts

Explainable AI model ConceptCLIP shows clinicians its reasoning

By
msadmin
August 19, 2026
News & Alerts

CHAI and The Joint Commission Partner to Launch AI Governance Playbooks for U.S. Healthcare Providers

By
Yu Chi Huang
June 16, 2025
News & Alerts

Study finds AI fingerprints on nine in ten biomedical papers

By
msadmin
August 22, 2026

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal